Bayer Acquires Facility from Novartis

Bayer Schering Pharma AG, (Berlin, Germany) has completed the acquisition of Novartis's biologies manufacturing facility in Emeryville, CA. Bayer will manufacture its multiple sclerosis drug, Betaseron, at the Emeryville site and retain full control of all manufacturing and process technology used in the production of Betaseron (interferon …